US FDA Approval Climate: What Do The Oral Testosterone Reviews Tell Us?

 
• By Ramsey Baghdadi

Second go-round for oral testosterone could have marked new boundary on how far FDA is willing to go in approving new entrants to a market with widespread historic off-label use and CV risks.

Elevator
Are approval prospects at the US FDA going up or down?

More from US FDA Performance Tracker

More from Regulatory Trackers